{"id":"https://openalex.org/W3095991104","doi":"https://doi.org/10.1182/blood-2020-139014","title":"High-Dose Melphalan Significantly Increases Mutational Burden in Multiple Myeloma Cells at Relapse: Results from a Randomized Study in Multiple Myeloma","display_name":"High-Dose Melphalan Significantly Increases Mutational Burden in Multiple Myeloma Cells at Relapse: Results from a Randomized Study in Multiple Myeloma","publication_year":2020,"publication_date":"2020-11-05","ids":{"openalex":"https://openalex.org/W3095991104","doi":"https://doi.org/10.1182/blood-2020-139014","mag":"3095991104"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-139014","doi":"https://doi.org/10.1182/blood-2020-139014","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-139014","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041668980","display_name":"Mehmet Samur","orcid":"https://orcid.org/0000-0002-9978-5682","observed_orcids":["https://orcid.org/0000-0002-9978-5682"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehmet K. Samur","raw_affiliation_strings":["Department of Data Science, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Data Science, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031149500","display_name":"Marco Roncador","orcid":"https://orcid.org/0000-0002-4574-4703","observed_orcids":["https://orcid.org/0000-0002-4574-4703"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marco Roncador","raw_affiliation_strings":["Dana-Farber Cancer Institute, Brookline, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Brookline, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071900604","display_name":"An\u0131l Akta\u015f-Samur","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anil Aktas-Samur","raw_affiliation_strings":["Department of Data Science, Dana Farber Cancer Institute, Boston, MA","Harvard School of Public Health, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Data Science, Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Harvard School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062468245","display_name":"Mariateresa Fulciniti","orcid":"https://orcid.org/0000-0002-1432-9742","observed_orcids":["https://orcid.org/0000-0002-1432-9742"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mariateresa Fulciniti","raw_affiliation_strings":["The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048162877","display_name":"Abdul Hamid Bazarbachi","orcid":"https://orcid.org/0000-0003-0243-4040","observed_orcids":["https://orcid.org/0000-0003-0243-4040"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abdul Hamid Bazarbachi","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Paris, France","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055748047","display_name":"Raphael Elie Szalat","orcid":"https://orcid.org/0000-0002-6198-3405","observed_orcids":["https://orcid.org/0000-0002-6198-3405"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raphael Szalat","raw_affiliation_strings":["Boston University School of Medicine, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston University School of Medicine, Boston, MA","institution_ids":["https://openalex.org/I111088046"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063099799","display_name":"Masood A. Shammas","orcid":"https://orcid.org/0000-0002-8932-6829","observed_orcids":["https://orcid.org/0000-0002-8932-6829"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Masood A. Shammas","raw_affiliation_strings":["The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston,","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston,","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079209072","display_name":"Adam Samuel Sperling","orcid":"https://orcid.org/0000-0002-9369-4413","observed_orcids":["https://orcid.org/0000-0002-9369-4413"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam S Sperling","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043526996","display_name":"Paul Gerard Guy Richardson","orcid":"https://orcid.org/0000-0002-7426-8865","observed_orcids":["https://orcid.org/0000-0002-7426-8865"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul G. Richardson","raw_affiliation_strings":["Medical Oncology, Harvard Medical School, Boston, MA","The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041002394","display_name":"Florence Magrangeas","orcid":"https://orcid.org/0000-0002-5031-3748","observed_orcids":["https://orcid.org/0000-0002-5031-3748"]},"institutions":[{"id":"https://openalex.org/I4405260337","display_name":"Universit\u00e9 de Nantes","ror":"https://ror.org/03kjmz544","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405260337","https://openalex.org/I97188460"]},{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Florence Magrangeas","raw_affiliation_strings":["Universit\u00e9 de Nantes, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 de Nantes, Nantes, France","institution_ids":["https://openalex.org/I4405260337","https://openalex.org/I97188460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073612758","display_name":"St\u00e9phane Minvielle","orcid":"https://orcid.org/0000-0003-1389-312X","observed_orcids":["https://orcid.org/0000-0003-1389-312X"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210092509","display_name":"Centre de Recherche en Canc\u00e9rologie et Immunologie Int\u00e9gr\u00e9e Nantes Angers","ror":"https://ror.org/003g1aw90","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I3019204325","https://openalex.org/I4210092509","https://openalex.org/I4210096427","https://openalex.org/I4210106090","https://openalex.org/I4210112910","https://openalex.org/I49451733","https://openalex.org/I97188460"]},{"id":"https://openalex.org/I4405260337","display_name":"Universit\u00e9 de Nantes","ror":"https://ror.org/03kjmz544","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405260337","https://openalex.org/I97188460"]},{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Stephane Minvielle","raw_affiliation_strings":["CRCINA, INSERM, CNRS, Angers University and Nantes University, Nantes, France","Universit\u00e9 de Nantes, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRCINA, INSERM, CNRS, Angers University and Nantes University, Nantes, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210092509","https://openalex.org/I4405260337"]},{"raw_affiliation_string":"Universit\u00e9 de Nantes, Nantes, France","institution_ids":["https://openalex.org/I4405260337","https://openalex.org/I97188460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028526208","display_name":"Anjan Thakurta","orcid":"https://orcid.org/0000-0003-0415-1706","observed_orcids":["https://orcid.org/0000-0003-0415-1706"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anjan Thakurta","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082698003","display_name":"Aurore Perrot","orcid":"https://orcid.org/0000-0003-0131-8689","observed_orcids":["https://orcid.org/0000-0003-0131-8689"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Aurore Perrot","raw_affiliation_strings":["Service d'H\u00e9matologie, IUCT- Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service d'H\u00e9matologie, IUCT- Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030565933","display_name":"Jill Corre","orcid":"https://orcid.org/0000-0003-1580-6106","observed_orcids":["https://orcid.org/0000-0003-1580-6106"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jill Corre","raw_affiliation_strings":["Unite de Genomique du Myelome, IUC-T Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unite de Genomique du Myelome, IUC-T Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103143602","display_name":"Philippe Moreau","orcid":"https://orcid.org/0000-0003-1780-8746","observed_orcids":["https://orcid.org/0000-0003-1780-8746"]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]},{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe Moreau","raw_affiliation_strings":["Department of Hematology, University Hospital of Nantes, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University Hospital of Nantes, Nantes, France","institution_ids":["https://openalex.org/I3019204325","https://openalex.org/I97188460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Anderson","raw_affiliation_strings":["The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050977500","display_name":"Giovanni Parmigiani","orcid":"https://orcid.org/0000-0002-8783-5961","observed_orcids":["https://orcid.org/0000-0002-8783-5961"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Giovanni Parmigiani","raw_affiliation_strings":["Data Science, Dana-Farber Cancer Institute, Boston, MA","Harvard T.H. Chan School of Public Health, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Data Science, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Harvard T.H. Chan School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063422967","display_name":"Herv\u00e9 Avet\u2010Loiseau","orcid":"https://orcid.org/0000-0002-3050-0140","observed_orcids":["https://orcid.org/0000-0002-3050-0140"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Herve Avet-Loiseau","raw_affiliation_strings":["Unite de Genomique du Myelome, IUC-T Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unite de Genomique du Myelome, IUC-T Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil C. Munshi","raw_affiliation_strings":["Boston VA Healthcare System, West Roxbury, MA","Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston VA Healthcare System, West Roxbury, MA","institution_ids":["https://openalex.org/I2801671727"]},{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":2.0507,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.88347372,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"136","issue":"Supplement 1","first_page":"4","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.8980000019073486},{"id":"https://openalex.org/keywords/high-dose-melphalan","display_name":"high-dose melphalan","score":0.9980000257492065},{"id":"https://openalex.org/keywords/mutation-burden","display_name":"mutational burden","score":0.8740000128746033},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.7099999785423279},{"id":"https://openalex.org/keywords/alkylating-agents","display_name":"alkylating agents","score":0.8629999756813049},{"id":"https://openalex.org/keywords/interstrand-crosslinks","display_name":"interstrand cross-links","score":0.8450000286102295},{"id":"https://openalex.org/keywords/indels","display_name":"indels","score":0.6100000143051147},{"id":"https://openalex.org/keywords/copy-number-alterations","display_name":"copy number alterations","score":0.7250000238418579},{"id":"https://openalex.org/keywords/structural-variants","display_name":"structural variants","score":0.8659999966621399},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.7540000081062317},{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.75}],"concepts":[{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.753353476524353},{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.7261964082717896},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6724604368209839},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.603148877620697},{"id":"https://openalex.org/C119054055","wikidata":"https://www.wikidata.org/wiki/Q1576681","display_name":"Indel","level":5,"score":0.5866962671279907},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4868318438529968},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.42242738604545593},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1593804955482483},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15000256896018982},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.13535791635513306},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.12253919243812561},{"id":"https://openalex.org/C153209595","wikidata":"https://www.wikidata.org/wiki/Q501128","display_name":"Single-nucleotide polymorphism","level":4,"score":0.08463266491889954}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2020-139014","doi":"https://doi.org/10.1182/blood-2020-139014","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-139014","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4313549658","https://openalex.org/W2581533094","https://openalex.org/W3163115321","https://openalex.org/W2555588530","https://openalex.org/W1851257302","https://openalex.org/W2979833294","https://openalex.org/W7207114715","https://openalex.org/W7220399598","https://openalex.org/W2562187656","https://openalex.org/W3177736519"],"abstract_inverted_index":{"We":[0,55,84],"recently":[1],"shown":[2],"that":[3,232],"high-dose":[4],"melphalan":[5,39,656],"(HDM)":[6],"followed":[7,117],"by":[8,78,118],"autologous":[9],"stem":[10],"cell":[11],"transplant":[12],"(ASCT)":[13],"as":[14,155,479,494],"first":[15],"line":[16],"therapy":[17],"in":[18,46,129,183,192,198,272,286,302,347,358,373,413,449,486,504,518,583,608,637,657,687,804,812,842,850],"young":[19],"(<66":[20],"yrs)":[21],"multiple":[22],"myeloma":[23,48],"(MM)":[24],"patients":[25,65,98,106,114,404,430,447,457,534,610],"significantly":[26,189,269],"improves":[27],"progression-free":[28],"survival":[29],"(IFM/DFCI":[30],"2009":[31,62],"study).":[32],"However,":[33],"the":[34,60,126,199,273,317,364,369,414,420,443,483,505,519,527,638,643,648,658],"impact":[35],"of":[36,161,194,224,304,319,363,393,422,442,529,619,627,647,653,660,727,739,750,761,772,783,794,858],"alkylating":[37],"agent":[38],"inducing":[40],"N-alkylpurine-monoadducts":[41],"forming":[42],"interstrand":[43],"crosslinks":[44],"(ICLs)":[45],"surviving":[47],"cells":[49,89],"remains":[50],"an":[51,724,747,758,769,780,791,855],"important":[52],"biological":[53],"question.":[54],"here":[56],"profiled":[57],"samples":[58,394,462,510,575],"from":[59,96,574],"IFM/DFCI":[61],"study,":[63],"where":[64],"were":[66,107,257,412,448,458,501,606],"randomized":[67],"to":[68,73,131,203,259,489,596],"RVD+HDM":[69],"vs":[70,147,208,214,248],"RVD":[71,110,116,204,245,444,461,490,520,551],"alone,":[72],"identify":[74],"genomic":[75],"changes":[76,285],"induced":[77],"HDM":[79,200,233,274,415,418,455,487,506,509,532,591],"and":[80,93,139,196,211,228,266,291,311,341,351,388,439,463,474,493,542,565,571,578,603,651,733,741],"observed":[81,315,355],"at":[82,91,94,163,268,316,339,356,536,576,588,600,611,616,640],"relapse.":[83,320,342,440,579,601],"analyzed":[85],"paired":[86],"purified":[87],"MM":[88],"collected":[90],"diagnosis":[92,164,340,438,577],"relapse":[95,357,617],"68":[97],"using":[99],"deep":[100],"(75X)":[101],"whole":[102],"genome":[103],"sequencing.":[104],"Forty-five":[105],"treated":[108,446],"with":[109,263,406,460],"only,":[111],"while":[112,329,548],"23":[113],"received":[115],"HDM.":[119],"There":[120],"was":[121,144,165,187,313,323,354,586],"no":[122],"significant":[123,284,300,345,594,625],"difference":[124],"between":[125,296,437],"2":[127],"groups":[128],"regard":[130],"disease":[132,639],"characteristics":[133],"including":[134,294,307],"sex,":[135],"age,":[136],"cytogenetic":[137],"risk,":[138],"best":[140],"response.":[141],"Median":[142],"follow-up":[143],"similar":[145,166,336,587],"(29":[146],"31":[148],"months,":[149],"respectively),":[150],"removing":[151],"longer":[152],"follow":[153],"up":[154],"a":[156,188,220,235,344,593],"confounding":[157],"variable.":[158],"The":[159,452,580],"number":[160,193,223,288],"mutations":[162,195,256,306,348,377,436,485,514,599,628],"on":[167,396,569,723,746,757,768,779,790,854],"both":[168,184,297,359,584],"arms":[169,585],"(7137":[170],"[IQR=3742]":[171],"vs.":[172,515],"7230":[173],"[IQR=3702],":[174],"p":[175],"value":[176],"=":[177],"0.67).":[178],"Although":[179],"mutational":[180,370],"load":[181],"increased":[182,324],"arms;":[185],"there":[186],"higher":[190,238,270],"increase":[191,346],"indels":[197,212],"arm":[201,416,522,533],"compared":[202,488],"alone":[205,521],"(mutations":[206],"5686":[207],"1745,":[209],"p=1.4e-5;":[210],"467":[213],"360,":[215],"p=":[216],"0.02,":[217],"respectively).":[218],"Using":[219],"model":[221],"incorporating":[222],"new":[225,435,484],"mutations,":[226],"depth,":[227],"purity,":[229],"we":[230,279,561,623],"found":[231],"causes":[234],"4.1":[236],"fold":[237],"mutation":[239,541,570],"accumulation":[240,626],"rate":[241,271],"per":[242],"month":[243],"than":[244],"only":[246,325,374,445,516,549,552],"(158.3":[247],"38.3":[249],"mutations/":[250],"month;":[251],"p=0.003).":[252],"Importantly,":[253],"newly":[254,375],"acquired":[255,376,431],"localized":[258],"regions":[260],"which":[261,613],"overlap":[262],"transcribed":[264],"regions,":[265],"accumulated":[267,511],"group":[275,456,553],"(p=0.009).":[276],"In":[277,621],"contrast,":[278],"did":[280],"not":[281,314],"observe":[282],"any":[283],"copy":[287],"alterations":[289],"(CNAs)":[290],"structural":[292],"variants,":[293],"translocations,":[295],"arms.":[298],"A":[299],"change":[301,636],"frequency":[303],"driver":[305,333],"RAS/RAF,":[308],"FAM46C,":[309],"TP53,":[310],"DIS3":[312],"time":[318,528],"Clonality":[321],"level":[322,338],"for":[326,645],"KRAS":[327],"(p=0.054),":[328],"all":[330],"other":[331],"specific":[332],"genes":[334,353,500],"had":[335,535,544,554],"clonality":[337],"Interestingly,":[343],"involving":[349],"MYO16":[350],"SLC7A8":[352],"arms,":[360],"implicating":[361],"components":[362],"induction":[365],"regimen":[366],"(RVD).":[367],"Investigating":[368],"signature":[371,397,410,466],"utilization":[372,398,411],"identified":[378,472],"4":[379],"signatures:":[380],"APOBEC,":[381],"HR":[382],"Double":[383],"Strand":[384],"Repair,":[385],"clock-like":[386],"signature,":[387],"unknown.":[389],"k-means":[390],"clustering":[391,405],"analysis":[392,471],"based":[395,568],"showed":[399,464],"four":[400],"distinct":[401],"clusters.":[402],"All":[403],"high":[407,630,654],"DNA":[408,496],"repair":[409,498],"(65%":[417],"patients),":[419],"majority":[421],"whom":[423],"achieved":[424],"CR":[425],"or":[426,546,556,729,752,763,774,785,796,860],"sCR":[427],"(74%);":[428],"these":[429],"8308":[432],"(range":[433],"3302-19107)":[434],"None":[441],"this":[450],"cluster.":[451],"remaining":[453],"35%":[454],"clustered":[459],"unknown":[465],"utilization.":[467],"Furthermore,":[468],"motif":[469],"enrichment":[470],"CYWR":[473],"ATGAGATV":[475],"(p":[476,523],"<":[477,524],"1e-130)":[478],"enriched":[480],"motifs":[481],"around":[482],"cohort.":[491],"Importantly":[492],"expected,":[495],"damage":[497],"pathway":[499],"frequently":[502],"targeted":[503],"group:":[507],"72%":[508],"DDR":[512,539],"gene":[513,540],"17%":[517],"0.001).":[525],"At":[526],"relapse,":[530,641],"100%":[531],"least":[537],"one":[538,555],"80%":[543],"two":[545],"more,":[547],"37%":[550],"more":[557,597],"such":[558],"mutation.":[559],"Finally,":[560],"have":[562],"reconstructed":[563],"phylogenetic":[564],"evolutionary":[566],"trajectories":[567],"copy-number":[572],"data":[573],"clonal":[581],"composition":[582],"diagnosis;":[589],"however,":[590],"caused":[592],"shift":[595],"subclonal":[598],"chromothripsis":[602],"chromoplexy":[604],"events":[605],"detected":[607],"30%":[609],"diagnosis,":[612],"remained":[614],"constant":[615],"regardless":[618],"treatment.":[620],"summary,":[622],"describe":[624],"following":[629],"dose":[631,655],"melphalan.":[632],"This":[633],"fundamental":[634],"molecular":[635],"suggests":[642],"need":[644],"reappraisal":[646],"optimal":[649],"use":[650],"sequencing":[652],"era":[659],"novel":[661],"agents.":[662],"Disclosures":[663],"Fulciniti:":[664],"NIH:":[665],"Research":[666,672,697],"Funding.":[667,673,698],"Richardson:Celgene/BMS,":[668],"Oncopeptides,":[669],"Takeda,":[670],"Karyopharm:":[671,830],"Thakurta:Oxford":[674],"University:":[675],"Other:":[676,736,824],"visiting":[677],"professor;":[678],"Bristol":[679],"Myers":[680,720],"Squibb:":[681,703,721],"Current":[682,684,801,809,839,847],"Employment,":[683],"equity":[685,802,810,840,848],"holder":[686,803,811,841,849],"publicly-traded":[688,805,813],"company.":[689],"Perrot:Amgen,":[690],"BMS/Celgene,":[691],"Janssen,":[692],"Sanofi,":[693],"Takeda:":[694,709,832],"Consultancy,":[695,700,704,707,714,717,846],"Honoraria,":[696],"Moreau:Sanofi:":[699],"Honoraria;":[701,705,708,710,712,715],"Celgene/Bristol-Myers":[702],"Janssen:":[706,788,836],"Novartis:":[711],"Abbvie:":[713],"Amgen:":[716],"Honoraria.":[718],"Anderson:Bristol":[719],"Membership":[722,745,756,767,778,789,853],"entity's":[725,748,759,770,781,792,856],"Board":[726,749,760,771,782,793,857],"Directors":[728,751,762,773,784,795,859],"advisory":[730,753,764,775,786,797,861],"committees;":[731,754,765,776,787],"Oncopep":[732,740],"C4":[734,742],"Therapeutics.:":[735],"Scientific":[737],"Founder":[738],"Therapeutics.;":[743],"Sanofi-Aventis:":[744],"Celgene:":[755],"Millenium-Takeda:":[766],"Gilead:":[777],"committees.":[798],"Parmigiani:Phaeno":[799],"Biotehnologies:":[800],"company;":[806,814,844],"CRA":[807],"Health:":[808],"Foundation":[815],"Medicine":[816],"Institute:":[817],"Consultancy;":[818,821,827,829,831,833,835,837,867],"Delphi":[819],"Diagnostics:":[820],"BayesMendel":[822],"Laboratory:":[823],"Co-lead.":[825],"Munshi:Amgen:":[826],"AbbVie:":[828],"Adaptive:":[834],"C4:":[838],"private":[843,851],"OncoPep:":[845],"company,":[852],"committees,":[862],"Patents":[863],"&":[864],"Royalties;":[865],"BMS:":[866],"Legend:":[868],"Consultancy.":[869]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":8}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2020-11-09T00:00:00"}